Home » Stocks » EW » Financials » Balance Sheet

Edwards Lifesciences Corporation (EW)

Stock Price: $100.71 USD -0.28 (-0.28%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed
After-hours: $100.00 -0.71 (-0.71%) Jun 18, 7:51 PM

Balance Sheet (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Cash & Equivalents1,1831,179714818930718654420311171396334219142183
Short-Term Investments219338242519341506785517211279--8.1049.40-
Cash & Cash Equivalents1,4031,5179571,3381,2711,2251,439937521451396334227191183
Cash Growth-7.54%58.59%-28.49%5.22%3.79%-14.88%53.57%79.69%15.74%13.73%18.56%47.31%18.62%4.6%-
Receivables603599537479415372331335357345303272205145127
Inventory802641607555397340297309281261204166152153142
Other Current Assets28322718617815811216514513211113011710997.3079.60
Total Current Assets3,0912,9842,2872,5492,2402,0482,2311,7261,2921,1691,033889692586532
Property, Plant & Equipment1,4891,140868680580483443422373304270252230228213
Long-Term Investments80258650656753238024121.9021.1021.8025.0022.3014.7034.3020.20
Goodwill and Intangibles1,5051,5041,4551,595831834399419452417382402413473454
Other Long-Term Assets35127420827632731220912283.5069.2057.5050.1050.9028.1028.20
Total Long-Term Assets4,1463,5043,0373,1172,2702,0081,292984930812735726708763715
Total Assets7,2376,4885,3245,6664,5104,0563,5232,7102,2221,9811,7671,6161,4001,3501,247
Accounts Payable86787787777053347642634634732027451.1065.6063.9048.90
Current Debt27.2025.50-598------41.80--150-
Other Current Liabilities0.000.000.0051.700.000.000.000.000.0015.4022.30239193166177
Total Current Liabilities8949028771,420533476426346347335338291259380226
Long-Term Debt668653594438822597598593189150-90.3017661.70236
Other Long-Term Liabilities1,10178471385253648030722720615712176.8087.4073.0035.30
Total Long-Term Liabilities1,7691,4371,3071,2901,3591,077906820395307121167263135271
Total Liabilities2,6632,3402,1832,7101,8911,5531,3321,166742643459458521515497
Total Debt6956795941,03682259759859318915041.8090.30176212236
Debt Growth2.37%14.31%-42.71%26.04%37.76%-0.2%0.84%213.31%25.86%259.81%-53.71%-48.55%-17.1%-10.26%-
Common Stock1705635841,127-1,089-651-550-459-13714.70226260237279331
Retained Earnings4,5653,7422,6951,9623,9063,3372,8422,0311,6541,3611,124906677549434
Comprehensive Income-161-156-139-133-198-183-101-27.60-37.90-37.50-42.10-7.90-35.407.50-15.80
Shareholders' Equity4,5744,1483,1402,9562,6192,5032,1911,5441,4791,3381,3081,158879835749
Total Liabilities and Equity7,2376,4885,3245,6664,5104,0563,5232,7102,2221,9811,7671,6161,4001,3501,247
Net Cash / Debt70883836330144962884134433230035424451.30-20.50-53.10
Net Cash / Debt Growth-15.56%131.07%20.46%-32.91%-28.51%-25.32%144.53%3.52%10.66%-15.30%45.32%375.24%--61.39%-
Net Cash Per Share1.141.340.580.480.700.971.320.510.480.440.520.360.08-0.03-0.08
Working Capital2,1972,0821,4101,1291,7081,5721,8051,380945833695599433206305
Book Value Per Share7.356.645.004.674.103.873.432.302.151.951.921.721.311.211.07

Showing 15 of 25 years

10 more years are available